根据英国的一项大型研究,一项新的血液测试结合了三个标记,确定有多达三倍心脏病发作风险的人。 A new blood test combining three markers identifies people with up to triple the heart attack risk, according to a large UK study.

根据对30多万英国成人进行的一项为期15年的研究,对脂质蛋白(a)、残留胆固醇和慢性胆固醇(HSCRP)进行的新的三部分血检可以辨别出有近三倍心脏病发作风险的人。 A new three-part blood test measuring lipoprotein(a), remnant cholesterol, and hsCRP can identify people with nearly triple the risk of a heart attack, according to a study of over 300,000 UK adults followed for 15 years. 所有三个标记都提高的人面临的风险要高得多,两个高标记的风险增加两倍以上,一个高标记的风险增加45%。 Those with all three markers elevated faced significantly higher risk, with two high markers increasing risk over twofold and one raising it by 45%. 这些测试检测出遗传风险、标准测试遗漏的有害脂肪以及心脏病的发炎关键驱动因素。 The tests detect genetic risk, harmful fats missed by standard tests, and inflammation—key drivers of heart disease. 测试虽然尚未例行进行,但广泛提供,可能有助于识别高风险个人,即使血压和LDL胆固醇等传统因素看来正常。 Though not yet routine, the tests are widely available and may help identify high-risk individuals even when traditional factors like blood pressure and LDL cholesterol appear normal. 专家支持使用它们作为个性化预防的一部分,尽管费用和保险范围仍然是障碍。 Experts support using them as part of personalized prevention, though cost and insurance coverage remain barriers. 调查结果是初步的,等待同行审议。 Findings are preliminary and await peer review.